Prisoners in 2015

E. Ann Carson, Ph.D., Elizabeth Anderson, Bureau of Justice Statistics

December 29, 2016    NCJ 250229

Presents final counts of prisoners under the jurisdiction of state and federal correctional authorities at yearend 2015, including admissions, releases, noncitizen inmates, and inmates age 17 or younger. The report describes prisoner populations by jurisdiction, most serious offense, and demographic characteristics. Selected findings on prison capacity and prisoners held in private prisons, local jails, and the U.S. military and territories are also included. Findings are based on data from BJSs National Prisoner Statistics program, which collects data from state departments of correction and the Federal Bureau of Prisons.

Highlights:

  • The total number of prisoners held under the jurisdiction of state and federal correctional authorities on December 31, 2015 (1,526,800) decreased by 35,500 (down more than 2%) from yearend 2014.
  • The federal prison population decreased by 14,100 prisoners from 2014 to 2015 (down almost 7%), accounting for 40% of the total change in the U.S. prison population.
  • After increasing during the previous 2 years, the number of state and federal female prisoners decreased by 1% in 2015.
  • State and federal prisons held 1,476,800 persons sentenced to more than 1 year on December 31, 2015.
  • The imprisonment rate in the United States decreased 3%, from 471 prisoners per 100,000 U.S. residents of all ages in 2014 to 458 prisoners per 100,000 in 2015.

Part of the Prisoners Series

Press Release
Summary (PDF 193K)
PDF (1.1M)
ASCII file (85K)
Comma-delimited format (Zip format 41K)

Help for using BJS products

About the Source Data
National Prisoner Statistics (NPS) Program

To cite this product, use the following link:
http://www.bjs.gov/index.cfm?ty=pbdetail&iid=5869

View All Publications and Products

Prisoners in 2015

E. Ann Carson, Ph.D., Elizabeth Anderson, Bureau of Justice Statistics

December 29, 2016    NCJ 250229

Presents final counts of prisoners under the jurisdiction of state and federal correctional authorities at yearend 2015, including admissions, releases, noncitizen inmates, and inmates age 17 or younger. The report describes prisoner populations by jurisdiction, most serious offense, and demographic characteristics. Selected findings on prison capacity and prisoners held in private prisons, local jails, and the U.S. military and territories are also included. Findings are based on data from BJSs National Prisoner Statistics program, which collects data from state departments of correction and the Federal Bureau of Prisons.

Highlights:

  • The total number of prisoners held under the jurisdiction of state and federal correctional authorities on December 31, 2015 (1,526,800) decreased by 35,500 (down more than 2%) from yearend 2014.
  • The federal prison population decreased by 14,100 prisoners from 2014 to 2015 (down almost 7%), accounting for 40% of the total change in the U.S. prison population.
  • After increasing during the previous 2 years, the number of state and federal female prisoners decreased by 1% in 2015.
  • State and federal prisons held 1,476,800 persons sentenced to more than 1 year on December 31, 2015.
  • The imprisonment rate in the United States decreased 3%, from 471 prisoners per 100,000 U.S. residents of all ages in 2014 to 458 prisoners per 100,000 in 2015.

Part of the Prisoners Series

Press Release
Summary (PDF 193K)
PDF (1.1M)
ASCII file (85K)
Comma-delimited format (Zip format 41K)

Help for using BJS products

About the Source Data
National Prisoner Statistics (NPS) Program

To cite this product, use the following link:
http://www.bjs.gov/index.cfm?ty=pbdetail&iid=5869

View All Publications and Products

Saahtain Ships One Million Halal Ready to Eat Meals

DUBAI, UAE, March 30, 2017 /PRNewswire/ —

Dubai, United Arab Emirates: In March, Halal food company Saahtain shipped its millionth ‘Tayyib’- brand Halal Meals Ready to Eat (MRE) to Mersin port, Turkey on their way to feed the desperate refugees in Aleppo, Syria, supporting a major food aid initiative by an alliance of Australian, Turkish, Malaysian and Singapore based Muslim charities.

     (Photo: http://mma.prnewswire.com/media/484342/Saahtain.jpg )

At the same time, emergency Tayyib Halal Ration Packs landed in a depot of the International Organization of Migration (IOM) in Bujumbura, Burundi and just a few days before Saahtain supported the United Nation High Commission for Refugees (UNHCR) with Halal meals boxes in Dakar, Senegal.

Saahtain is a proud UAE pioneer in the GCC and has supported Muslim charities and Corporate Social Responsibility (CSR) initiatives globally since 2014.

“We see ourselves as a growing member of the UAE’s Islamic Economy”, says CEO, Adeel Khan, “Our business solves many pain points in the Halal Food sector. From feeding Muslim Travelers to Halal Humanitarian Food Relief, we are at the forefront delivering innovative solutions”. Saahtain is the only producer of Halal Ready-to-Eat Meals in the Gulf region and provides over ninety (90) International recipes, many of them with three (3) years shelf life. Its unique and proprietary methods of preserving natural food was used in 2015 to support a leading NGO in Abu Dhabi in preserving excess food from hospitality sector. Such technology has sizable potential to support food bank initiatives in the region.

Saahtain counts leading blue chip corporates like HSBC, Citibank, PepsiCo amongst its clients who have successfully executed effective Corporate Social Responsibility campaigns with our Tayyib Halal MREs. It has also worked with leading charities like Dubai Charity, UAE Red Crescent, Muslim Aid Australia and Haji & Mu’tamer’s Gift Charity, Saudi Arabia.

In addition to its humanitarian Food Relief brand called Tayyib, Saahtain has also launched its Halal MREs for Muslim travelers called AlGourmet. Saahtain successfully exhibited at IDEX, the Abu Dhabi defense exhibition last month showcasing itself as a unique UAE SME capable of serving the challenging military and emergency sector.

As we ship our millionth meal we are proud to be an active halal participant in the Year of Giving of HH Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the United Arab Emirates, and Emir of Dubai.

Technical Reports on Medical Supplies Stocks — Endologix, Becton, Dickinson, Antares Pharma, and C. R. Bard

NEW YORK, March 30, 2017 /PRNewswire/ —

Stock-Callers.com navigates the Medical Instruments and Supplies space, which is involved in the research, development, and production of non-electronic medical, surgical, dental, and veterinary instruments and apparatus. Equities in today’s lineup are: Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Co. (NYSE: BDX), Antares Pharma Inc. (NASDAQ: ATRS), and C. R. Bard Inc. (NYSE: BCR). Download the free research reports on these stocks today:

http://stock-callers.com/registration

Endologix  

Irvine, California headquartered Endologix Inc.’s shares declined 0.21%, closing Wednesday’s trading session at $7.07. The stock recorded a trading volume of 814,017 shares. Shares of the Company have advanced 6.88% in the last month, 34.06% over the previous three months, and 23.51% since the start of this year. The stock is trading 5.63% above its 50-day moving average. Additionally, shares of Endologix, which develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the US and internationally, have a Relative Strength Index (RSI) of 58.30. See our free and comprehensive research report on ELGX at:

http://stock-callers.com/registration/?symbol=ELGX

Becton, Dickinson 

On Wednesday, shares in Franklin Lakes, New Jersey headquartered Becton, Dickinson and Co. (BDX) recorded a trading volume of 454,533 shares. The stock fell 0.03%, ending the day at $183.87. The Company’s shares have advanced 0.85% in the past month, 10.50% in the previous three months, and 11.51% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 2.39% and 6.43%, respectively. Furthermore, shares of Becton, Dickinson and Co., which develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide, have an RSI of 57.23.

On March 01st, 2017, BDX announced that it was awarded a contract worth up to $100 million with the Defense Health Agency (DHA) under the US Department of Defense for its Pyxis™ ES System. Under the purchase agreement, BDX will provide its enterprise-wide medication dispensing technology platform across DHA’s 115 military inpatient health facilities and military inpatient pharmacies. BDX free research report PDF is just a click away at:

http://stock-callers.com/registration/?symbol=BDX

Antares Pharma  

Ewing, New Jersey headquartered Antares Pharma Inc.’s stock finished the day 0.72% lower at $2.74 with a total trading volume of 894,350 shares. The Company’s shares have advanced 11.38% in the last one month, 16.60% in the previous three months, and 17.60% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 13.72% and 54.96%, respectively. Additionally, shares of Antares Pharma, which focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide, have an RSI of 60.54.

On March 14th, 2017, Antares Pharma reported operating progress and financial results for Q4 2016 and full year ended December 31st, 2016.  The Company reported revenue of $14.2 million for Q4, and $52.2 million for the full year. Net loss per share was $0.03 and $0.16 for Q4 and full year 2016, respectively. Sign up for your complimentary report on ATRS at:

http://stock-callers.com/registration/?symbol=ATRS

C. R. Bard  

Shares in Murray Hill, New Jersey headquartered C. R. Bard Inc. ended yesterday’s session 0.32% lower at $249.68. The stock recorded a trading volume of 359,420 shares. The Company’s shares have advanced 1.81% in the last one month, 11.83% over the previous three months, and 11.26% since the start of this year. The stock is trading 3.02% and 9.96% above its 50-day and 200-day moving averages, respectively. Moreover, shares of C. R. Bard, which together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide, have an RSI of 59.68. Register for free on Stock-Callers.com and download the latest research report on BCR at:

http://stock-callers.com/registration/?symbol=BCR

Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the „Author”) and is fact checked and reviewed by a third party research service company (the „Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the „Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY 

SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://stock-callers.com/legal-disclaimer/

CONTACT
For any questions, inquiries, or comments reach out to us directly. If youre a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Chelmsford Park SA

Military Hydration Products Market Recent Industry Trends and Projected Industry Growth, 2015 – 2025

The military operations are constantly going through exhausting preparations to make sure that satisfactory and safe water supplies are available during training and other military operations. While training, being hydrated is an essential component for soldiers to keep them physically fit and enhance their overall performance. Proper hydration of soldiers is a major concern which has triggered military activities to produce more niche products to cater to the cause of hydration. Advancement in military activities and operations necessitated the development to produce advance military hydration products.  can cater to a lot of medical and emergency distribution centres. Furthermore witnessing this opportunity, few defence and military equipment manufacturers are engaged in manufacturing of defence and military hydration products and equipment to cater to the global market. Nowadays military hydration products are not only restricted to military troops and soldiers but individuals involved in sports and other outdoor and adventurous activities like trekking are also taking advantage of military hydration products.

Global Military Hydration Products Market: Drivers & Restraints

The rising concern for health and safety issues in defence and military operations is a major factor driving the demand for global military hydration products market. Moreover, the demand for military hydration products is directly influenced by rising military and defence expenditures across the globe. Encouraging the drinking of fresh water and being hydrated makes good sense for healthcare professionals and individuals globally. It not only helps to reduce more common ailments but also improves wellbeing and reduces the volume of medicine consumption that are required. Supporting government norms to buy and spend more on health and safety products like military hydration will fuel the demand for global military hydration products in the future.

Request For Report Sample@  http://www.futuremarketinsights.com/reports/sample/rep-gb-705         

Global Military Hydration Products Market: Segmentation

On the basis of product type, the global military hydration products market is segmented into

  • Hydration packs
  • Bags
  • Water Bottles
  • Hydration accessories
  • Purification & Filtration Products
  • Reservoirs
  • Others

Global Military Hydration Products Market: Region-wise Outlook

In terms of geography, the global military hydration products market has been divided in to seven key regions including North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Middle East & Africa and Japan. The global military hydration products market is expected to register healthy CAGR during the forecast period and offers considerable commercial potential. However regions of Latin America and emerging economies of Asia-Pacific are major hotspots for global military hydration products. However, the military hydration products in Europe is expected to register high CAGR as compared to the global market. India and China among the Asia-Pacific region are expected to grow steadily during the forecast period.

Visit For TOC@  http://www.futuremarketinsights.com/toc/rep-gb-705

Global Military Hydration Products Market: Key Players

Some of the market participants in the global military hydration products market include Source Tactical Gear, CamelBak, Platypus and Cera Products Inc.

PEN Inc. (PENC: OTCQB) | PEN Inc. Announces Fourth Quarter and Full Year 2016 Financial Results

MIAMI, FL–(Marketwired – Mar 30, 2017) – PEN Inc. (OTCQB: PENC) („PEN” or „the Company”), a global leader in developing, commercializing and marketing consumer and industrial products enabled by nanotechnology, reported financial results for its fourth quarter and full year ended December 31, 2016.

For the year ended December 31, 2016, PEN generated positive cash flow from operations and achieved a significant reduction in net loss.

Scott Rickert, PEN’s President, Chairman and CEO, said: „We closed 2016 on a strong note, generating over $400,000 in operating cash flow for the year and significantly reducing net loss despite a decline in sales from our traditional health and safety products.

„I am impressed with the progress we have made in right-sizing operations and positioning the Company for future success. Our new leadership in Ohio, supported by a top-notch team, has been instrumental in putting us on the path to transforming a niche optical products business into PEN Brands — a nanotechnology company focused on developing products in the areas of health, safety and sustainability for a broad range of retail and institutional customers. 

„Looking ahead, we plan to further streamline our Ohio operations and reenergize sales and marketing as we rebrand several of our existing products into the market over the next twelve months. We remain confident that our environmentally-friendly surface protector has the potential to revolutionize the household cleaning products industry. I am excited about the opportunities for PEN in the year ahead, and believe that we have the products, technology and team in place to build a high-growth company that solves big problems in large addressable markets.” 

Fourth Quarter 2016 Financial Results

For the three months ended December 31, 2016, total revenues were $1,919,830 compared to revenues of $2,293,190 in the comparable period in 2015.

For the fourth quarter of 2016, overall gross profit amounted to $650,394, compared to $892,769 for the fourth quarter of 2015. Gross margin was 34%, compared to 39% in the year ago period. The decrease in gross margin was attributable lower gross margins from the Product and Contract services segments during the quarter. 

Operating expenses totaled $794,507 in the fourth quarter of 2016, down 35% from $1,212,466 in the fourth quarter of 2015. The decrease was due to lower salaries, wages and related benefits, research and development expenses and selling and marketing expenses. Operating expenses for the fourth quarter of 2015 include a non-cash impairment charge of certain intangible assets acquired in the business combination totaling $188,051. There was no such expense in the fourth quarter of 2016. 

Operating loss was $144,113 in the fourth quarter of 2016, compared to an operating loss of $319,697 in the fourth quarter of 2015.

Other income was $44,640 in the fourth quarter of 2016, compared to other expense of $24,470 in the fourth quarter of 2015. The increase was primarily related to rental income for subleased office space in Austin. 

Net loss for the three months ended December 31, 2016 amounted to $99,473 or ($0.03) per basic and diluted share, as compared to a net loss of $344,167 or ($0.12) per basic and diluted share, for the three months ended December 31, 2015. 

Basic and diluted earnings per share were based on 3,029,202 and 2,980,868 weighted average shares outstanding, respectively, for the three months ended December 31, 2016 and 2015. All share and per share information has been adjusted to reflect a 1-for-180 reverse stock split effective January 26, 2016.

PEN Brands’ Health and Safety Products – Product Segment

Sales from PEN’s Product segment for the fourth quarter of 2016 were $1,720,642, down 12% from $1,946,459 for the three months ended December 31, 2015. 

Gross margin in the Product segment in the fourth quarter of 2016 was 40%, compared to 45% in the year ago period, primarily due to differences in the assortment of products sold. 

PEN Design Center – Contract Services Segment

Revenues from the Contract services segment for the fourth quarter of 2016 were $199,188 compared to $346,731 in the fourth quarter of 2015. 

Gross margin from the Contract services segment in the fourth quarter of 2016 was negative 17%, compared to 4% in the year ago period. 

Full Year Results

For the year ended December 31, 2016, total revenues were $8,115,657 down 16% from revenues of $9,685,072 in 2015. Gross profit was $2,805,687 in 2016, down 16% from gross profit of $3,340,939 in 2015. Gross margin was 35%, relatively unchanged from 2015. Net loss 2016 amounted to $556,001 or ($0.18) per basic and diluted share, as compared to net loss of $1,869,247, or ($0.63) per basic and diluted share, for 2015. Basic and diluted earnings per share were based on 3,012,460 and 2,974,847 weighted average shares outstanding, respectively, for years ended December 31, 2016 and 2015. All share and per share information has been adjusted to reflect a 1-for-180 reverse stock split effective January 26, 2016.

Financial Condition

As of December 31, 2016, PEN held cash and cash equivalents of $189,128 as compared to $262,519 at December 31, 2015. As of December 31, 2016, PEN had a working capital deficit of $1,072,691 compared to a working capital deficit of $889,657 at December 31, 2015. 

During 2016, PEN had positive cash flow from operations, generating $444,453 in cash flow from operations. The Company generated $19,586 in cash flow from investing activities in 2016, which was primarily related to the sale of property and equipment in Contract services segment. As of December 31, 2016, the Company had short-term debt of $1,070,137 compared to $1,363,128 as of December 31, 2015. 

About PEN Inc.

PEN Inc. (OTCQB: PENC) is a leader in developing, commercializing, and marketing consumer and industrial products enabled by nanotechnology that solve everyday problems for customers in the health, transportation, military, sports, and safety industries. Through PEN’s wholly-owned subsidiary Nanofilm Ltd., the Company develops, manufactures and sells products based on nanotechnology including the ULTRA CLARITY® brand eyeglass cleaner, CLARITY DEFOG IT™ brand defogging products and CLARITY ULTRASEAL® nanocoating products for glass and ceramics. The Company also sells an environmentally friendly surface protector, fortifier, and cleaner through a wholly-owned subsidiary, PEN Technology, LLC. The Company’s Applied Nanotech, Inc. subsidiary in Austin, Texas functions as the Design Center conducting contract services for government and private customers and new product development for PEN focusing on innovative and advanced product solutions in the areas of safety, health, and sustainability. For more information about PEN, visit www.penc.us.

Safe Harbor Statement

This press release contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report on Form 10-K for the fiscal year ended December 31, 2016, and in reports subsequently filed by us with the Securities and Exchange Commission („SEC”). All documents are available through the SEC’s Electronic Data Gathering Analysis and Retrieval System (EDGAR) at www.sec.gov or from our website listed above. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.

   
PEN INC. AND SUBSIDIARIES  
CONSOLIDATED BALANCE SHEETS  
           
  December 31,     December 31,  
  2016     2015  
               
ASSETS              
CURRENT ASSETS:              
  Cash $ 189,128     $ 262,519  
  Accounts receivable, net   722,845       1,100,352  
  Accounts receivable – related party   10,474       11,984  
  Inventory   1,035,499       1,083,385  
  Prepaid expenses and other current assets   75,080       194,950  
  Total Current Assets   2,033,026       2,653,190  
               
OTHER ASSETS:              
  Property, plant and equipment, net   709,627       897,358  
  Other assets   51,078       32,103  
  Total Other Assets   760,705       929,461  
               
TOTAL ASSETS $ 2,793,731     $ 3,582,651  
               
LIABILITIES AND STOCKHOLDERS’ DEFICIT              
               
CURRENT LIABILITIES:              
  Bank revolving line of credit $ 979,688     $ 1,288,748  
  Current portion of notes payable   90,449       74,380  
  Accounts payable   1,078,527       1,259,865  
  Accounts payable – related parties   52,887       27,064  
  Accrued expenses   904,166       871,098  
  Deferred revenue         21,692  
               
  Total Current Liabilities   3,105,717       3,542,847  
               
LONG-TERM LIABILITIES:              
  Notes payable, net of current portion   266,110       312,139  
               
  Total Long-Term Liabilities   266,110       312,139  
               
  Total Liabilities   3,371,827       3,854,986  
               
Commitments and Contingencies              
               
STOCKHOLDERS’ DEFICIT:              
  Preferred stock, $0.0001 par value, 20,000,000 shares authorized; no shares issued and outstanding          
  Class A common stock: $0.0001 par value, 7,200,000 shares authorized; 1,367,431 and 1,336,759 issued and outstanding at December 31, 2016 and 2015, respectively   136       134  
  Class B common stock: $0.0001 par value, 2,500,000 shares authorized; 1,402,104 and 1,395,678 issued and outstanding at December 31, 2016 and 2015, respectively   140       139  
  Class Z common stock: $0.0001 par value, 300,000 shares authorized; 262,631 shares issued and outstanding at December 31, 2016 and 2015   26       26  
  Additional paid-in capital   5,321,769       5,071,532  
  Accumulated deficit   (5,900,167 )     (5,344,166 )
               
Total Stockholders’ Deficit   (578,096 )     (272,335 )
               
Total Liabilities and Stockholders’ Deficit $ 2,793,731     $ 3,582,651  
               
               
               
PEN INC. AND SUBSIDIARIES  
CONSOLIDATED STATEMENTS OF OPERATIONS  
                       
  For the Three Months Ended     For the Years Ended  
  December 31,     December 31,  
  2016     2015     2016     2015  
  (Unaudited)     (Unaudited)              
REVENUES:                              
  Products $ 1,720,642     $ 1,946,459     $ 7,111,947     $ 7,920,148  
  Contract services   199,188       346,731       1,003,710       1,764,924  
                               
  Total Revenues   1,919,830       2,293,190       8,115,657       9,685,072  
                               
COST OF REVENUES:                              
  Products   1,036,450       1,066,584       4,212,079       4,561,506  
  Research and development services   232,986       333,837       1,097,891       1,782,627  
                               
  Total Cost of Revenues   1,269,436       1,400,421       5,309,970       6,344,133  
                               
GROSS PROFIT   650,394       892,769       2,805,687       3,340,939  
                               
OPERATING EXPENSES:                              
  Selling and marketing expenses   42,755       65,574       220,029       280,173  
  Salaries, wages and related benefits   272,503       472,708       1,513,536       2,214,956  
  Research and development   53,868       124,055       290,402       744,346  
  Professional fees   148,787       113,962       513,237       660,584  
  General and administrative expenses   276,594       248,116       1,015,503       1,016,752  
  Impairment loss         188,051             188,051  
                               
  Total Operating Expenses   794,507       1,212,466       3,552,707       5,104,862  
                               
LOSS FROM OPERATIONS   (144,113 )     (319,697 )     (747,020 )     (1,763,923 )
                               
OTHER INCOME (EXPENSES):                              
  Interest expenses   (22,820 )     (26,848 )     (105,090 )     (117,879 )
  Other income, net   67,460       2,378       296,109       12,255  
                               
  Total Other Income/(Expense)   44,640       (24,470 )     191,019       (105,324 )
                               
NET LOSS $ (99,473 )   $ (344,167 )   $ (556,001 )   $ (1,869,247 )
                               
NET LOSS PER COMMON SHARE:                              
  Basic $ (0.03 )   $ (0.12 )   $ (0.18 )   $ (0.63 )
  Diluted $ (0.03 )   $ (0.12 )   $ (0.18 )   $ (0.63 )
                               
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:                              
  Basic   3,029,202       2,980,868       3,012,460       2,974,847  
  Diluted   3,029,202       2,980,868       3,012,460       2,974,847  
                                 
                                 
                                 
PEN INC. AND SUBSIDIARIES  
CONSOLIDATED STATEMENTS OF CASH FLOWS  
           
  For Years Ended  
  December 31,  
  2016     2015  
               
CASH FLOWS FROM OPERATING ACTIVITIES              
  Net loss $ (556,001 )   $ (1,869,247 )
  Adjustments to reconcile net loss to net cash provided by (used in) operating activities:              
    Change in inventory obsolescence reserve   56,861       (35,652 )
    Bad debt expense   12,021       641  
    Impairment loss         188,051  
    Depreciation and amortization expense   182,986       252,899  
    Amortization of deferred lease incentives   12,830       (12,830 )
    Change in value of stock appreciation rights         6,962  
    Change in value of equity credits         (11,024 )
    Gain on sale of property and equipment   (23,586 )      
    Loss on disposal of property and equipment   8,745        
    Gain on settlement of accounts payable   (50,879 )      
    Gain on settlement of accrued salary   (36,973 )      
    Stock-based compensation   202,240       241,240  
    Change in operating assets and liabilities:              
      Accounts receivable   365,486       (67,998 )
      Accounts receivable – related party   1,510       26,262  
      Inventory   (8,975 )     509,367  
      Prepaid expenses and other assets   100,895       14,867  
      Accounts payable   (130,459 )     (166,600 )
      Accounts payable – related parties   25,823       27,064  
      Accrued expenses   303,621       98,888  
      Deferred revenue   (21,692 )     (7,098 )
               
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES   444,453       (804,208 )
               
CASH FLOWS FROM INVESTING ACTIVITIES              
  Proceeds from sales of property and equipment   23,586        
  Purchases of property and equipment   (4,000 )     (248,123 )
               
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES   19,586       (248,123 )
               
CASH FLOWS FROM FINANCING ACTIVITIES              
  Proceeds from sale of common stock   50,000        
  Payment of issuance costs related to sale of common stock   (2,000 )      
  Proceeds from bank line of credit   6,815,000       8,156,000  
  Repayment of bank lines of credit   (7,319,231 )     (7,640,596 )
  Proceeds from bank loan         371,901  
  Repayment of bank loans   (74,380 )     (37,190 )
  Repayment of loan to third party   (6,819 )      
               
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES   (537,430 )     850,115  
               
NET DECREASE IN CASH   (73,391 )     (202,216 )
               
CASH, beginning of period   262,519       464,735  
               
CASH, end of period $ 189,128     $ 262,519  
               
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION              
Cash paid during the period for interest              
  Interest $ 105,090     $ 117,879  
  Income taxes $     $  
               
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:              
  Common stock issued for convertible notes and accrued interest $     $ 13,725  
  Common stock issued for accrued expenses $     $ 123,285  
  Reclassification of accrued salary to notes payable – long-term $ 51,239     $ 51,808  
                 

Copyright © 2017 Marketwired. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Technical Reports on Medical Supplies Stocks — Endologix, Becton, Dickinson, Antares Pharma, and C. R. Bard

NEW YORK, March 30, 2017 /PRNewswire/ —

Stock-Callers.com navigates the Medical Instruments and Supplies space, which is involved in the research, development, and production of non-electronic medical, surgical, dental, and veterinary instruments and apparatus. Equities in today’s lineup are: Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Co. (NYSE: BDX), Antares Pharma Inc. (NASDAQ: ATRS), and C. R. Bard Inc. (NYSE: BCR). Download the free research reports on these stocks today:

http://stock-callers.com/registration

Endologix  

Irvine, California headquartered Endologix Inc.’s shares declined 0.21%, closing Wednesday’s trading session at $7.07. The stock recorded a trading volume of 814,017 shares. Shares of the Company have advanced 6.88% in the last month, 34.06% over the previous three months, and 23.51% since the start of this year. The stock is trading 5.63% above its 50-day moving average. Additionally, shares of Endologix, which develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the US and internationally, have a Relative Strength Index (RSI) of 58.30. See our free and comprehensive research report on ELGX at:

http://stock-callers.com/registration/?symbol=ELGX

Becton, Dickinson 

On Wednesday, shares in Franklin Lakes, New Jersey headquartered Becton, Dickinson and Co. (BDX) recorded a trading volume of 454,533 shares. The stock fell 0.03%, ending the day at $183.87. The Company’s shares have advanced 0.85% in the past month, 10.50% in the previous three months, and 11.51% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 2.39% and 6.43%, respectively. Furthermore, shares of Becton, Dickinson and Co., which develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide, have an RSI of 57.23.

On March 01st, 2017, BDX announced that it was awarded a contract worth up to $100 million with the Defense Health Agency (DHA) under the US Department of Defense for its Pyxis™ ES System. Under the purchase agreement, BDX will provide its enterprise-wide medication dispensing technology platform across DHA’s 115 military inpatient health facilities and military inpatient pharmacies. BDX free research report PDF is just a click away at:

http://stock-callers.com/registration/?symbol=BDX

Antares Pharma  

Ewing, New Jersey headquartered Antares Pharma Inc.’s stock finished the day 0.72% lower at $2.74 with a total trading volume of 894,350 shares. The Company’s shares have advanced 11.38% in the last one month, 16.60% in the previous three months, and 17.60% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 13.72% and 54.96%, respectively. Additionally, shares of Antares Pharma, which focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies worldwide, have an RSI of 60.54.

On March 14th, 2017, Antares Pharma reported operating progress and financial results for Q4 2016 and full year ended December 31st, 2016.  The Company reported revenue of $14.2 million for Q4, and $52.2 million for the full year. Net loss per share was $0.03 and $0.16 for Q4 and full year 2016, respectively. Sign up for your complimentary report on ATRS at:

http://stock-callers.com/registration/?symbol=ATRS

C. R. Bard  

Shares in Murray Hill, New Jersey headquartered C. R. Bard Inc. ended yesterday’s session 0.32% lower at $249.68. The stock recorded a trading volume of 359,420 shares. The Company’s shares have advanced 1.81% in the last one month, 11.83% over the previous three months, and 11.26% since the start of this year. The stock is trading 3.02% and 9.96% above its 50-day and 200-day moving averages, respectively. Moreover, shares of C. R. Bard, which together with its subsidiaries, designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide, have an RSI of 59.68. Register for free on Stock-Callers.com and download the latest research report on BCR at:

http://stock-callers.com/registration/?symbol=BCR

Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY 

SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://stock-callers.com/legal-disclaimer/

CONTACT
For any questions, inquiries, or comments reach out to us directly. If youre a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

PEN Inc. Announces Fourth Quarter and Full Year 2016 Financial Results

MIAMI, FL–(Marketwired – Mar 30, 2017) – PEN Inc. (OTCQB: PENC) („PEN” or „the Company”), a global leader in developing, commercializing and marketing consumer and industrial products enabled by nanotechnology, reported financial results for its fourth quarter and full year ended December 31, 2016.

For the year ended December 31, 2016, PEN generated positive cash flow from operations and achieved a significant reduction in net loss.

Scott Rickert, PEN’s President, Chairman and CEO, said: „We closed 2016 on a strong note, generating over $400,000 in operating cash flow for the year and significantly reducing net loss despite a decline in sales from our traditional health and safety products.

„I am impressed with the progress we have made in right-sizing operations and positioning the Company for future success. Our new leadership in Ohio, supported by a top-notch team, has been instrumental in putting us on the path to transforming a niche optical products business into PEN Brands — a nanotechnology company focused on developing products in the areas of health, safety and sustainability for a broad range of retail and institutional customers. 

„Looking ahead, we plan to further streamline our Ohio operations and reenergize sales and marketing as we rebrand several of our existing products into the market over the next twelve months. We remain confident that our environmentally-friendly surface protector has the potential to revolutionize the household cleaning products industry. I am excited about the opportunities for PEN in the year ahead, and believe that we have the products, technology and team in place to build a high-growth company that solves big problems in large addressable markets.” 

Fourth Quarter 2016 Financial Results

For the three months ended December 31, 2016, total revenues were $1,919,830 compared to revenues of $2,293,190 in the comparable period in 2015.

For the fourth quarter of 2016, overall gross profit amounted to $650,394, compared to $892,769 for the fourth quarter of 2015. Gross margin was 34%, compared to 39% in the year ago period. The decrease in gross margin was attributable lower gross margins from the Product and Contract services segments during the quarter. 

Operating expenses totaled $794,507 in the fourth quarter of 2016, down 35% from $1,212,466 in the fourth quarter of 2015. The decrease was due to lower salaries, wages and related benefits, research and development expenses and selling and marketing expenses. Operating expenses for the fourth quarter of 2015 include a non-cash impairment charge of certain intangible assets acquired in the business combination totaling $188,051. There was no such expense in the fourth quarter of 2016. 

Operating loss was $144,113 in the fourth quarter of 2016, compared to an operating loss of $319,697 in the fourth quarter of 2015.

Other income was $44,640 in the fourth quarter of 2016, compared to other expense of $24,470 in the fourth quarter of 2015. The increase was primarily related to rental income for subleased office space in Austin. 

Net loss for the three months ended December 31, 2016 amounted to $99,473 or ($0.03) per basic and diluted share, as compared to a net loss of $344,167 or ($0.12) per basic and diluted share, for the three months ended December 31, 2015. 

Basic and diluted earnings per share were based on 3,029,202 and 2,980,868 weighted average shares outstanding, respectively, for the three months ended December 31, 2016 and 2015. All share and per share information has been adjusted to reflect a 1-for-180 reverse stock split effective January 26, 2016.

PEN Brands’ Health and Safety Products – Product Segment

Sales from PEN’s Product segment for the fourth quarter of 2016 were $1,720,642, down 12% from $1,946,459 for the three months ended December 31, 2015. 

Gross margin in the Product segment in the fourth quarter of 2016 was 40%, compared to 45% in the year ago period, primarily due to differences in the assortment of products sold. 

PEN Design Center – Contract Services Segment

Revenues from the Contract services segment for the fourth quarter of 2016 were $199,188 compared to $346,731 in the fourth quarter of 2015. 

Gross margin from the Contract services segment in the fourth quarter of 2016 was negative 17%, compared to 4% in the year ago period. 

Full Year Results

For the year ended December 31, 2016, total revenues were $8,115,657 down 16% from revenues of $9,685,072 in 2015. Gross profit was $2,805,687 in 2016, down 16% from gross profit of $3,340,939 in 2015. Gross margin was 35%, relatively unchanged from 2015. Net loss 2016 amounted to $556,001 or ($0.18) per basic and diluted share, as compared to net loss of $1,869,247, or ($0.63) per basic and diluted share, for 2015. Basic and diluted earnings per share were based on 3,012,460 and 2,974,847 weighted average shares outstanding, respectively, for years ended December 31, 2016 and 2015. All share and per share information has been adjusted to reflect a 1-for-180 reverse stock split effective January 26, 2016.

Financial Condition

As of December 31, 2016, PEN held cash and cash equivalents of $189,128 as compared to $262,519 at December 31, 2015. As of December 31, 2016, PEN had a working capital deficit of $1,072,691 compared to a working capital deficit of $889,657 at December 31, 2015. 

During 2016, PEN had positive cash flow from operations, generating $444,453 in cash flow from operations. The Company generated $19,586 in cash flow from investing activities in 2016, which was primarily related to the sale of property and equipment in Contract services segment. As of December 31, 2016, the Company had short-term debt of $1,070,137 compared to $1,363,128 as of December 31, 2015. 

About PEN Inc.

PEN Inc. (OTCQB: PENC) is a leader in developing, commercializing, and marketing consumer and industrial products enabled by nanotechnology that solve everyday problems for customers in the health, transportation, military, sports, and safety industries. Through PEN’s wholly-owned subsidiary Nanofilm Ltd., the Company develops, manufactures and sells products based on nanotechnology including the ULTRA CLARITY® brand eyeglass cleaner, CLARITY DEFOG IT™ brand defogging products and CLARITY ULTRASEAL® nanocoating products for glass and ceramics. The Company also sells an environmentally friendly surface protector, fortifier, and cleaner through a wholly-owned subsidiary, PEN Technology, LLC. The Company’s Applied Nanotech, Inc. subsidiary in Austin, Texas functions as the Design Center conducting contract services for government and private customers and new product development for PEN focusing on innovative and advanced product solutions in the areas of safety, health, and sustainability. For more information about PEN, visit www.penc.us.

Safe Harbor Statement

This press release contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report on Form 10-K for the fiscal year ended December 31, 2016, and in reports subsequently filed by us with the Securities and Exchange Commission („SEC”). All documents are available through the SEC’s Electronic Data Gathering Analysis and Retrieval System (EDGAR) at www.sec.gov or from our website listed above. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.

   
PEN INC. AND SUBSIDIARIES  
CONSOLIDATED BALANCE SHEETS  
           
  December 31,     December 31,  
  2016     2015  
               
ASSETS              
CURRENT ASSETS:              
  Cash $ 189,128     $ 262,519  
  Accounts receivable, net   722,845       1,100,352  
  Accounts receivable – related party   10,474       11,984  
  Inventory   1,035,499       1,083,385  
  Prepaid expenses and other current assets   75,080       194,950  
  Total Current Assets   2,033,026       2,653,190  
               
OTHER ASSETS:              
  Property, plant and equipment, net   709,627       897,358  
  Other assets   51,078       32,103  
  Total Other Assets   760,705       929,461  
               
TOTAL ASSETS $ 2,793,731     $ 3,582,651  
               
LIABILITIES AND STOCKHOLDERS’ DEFICIT              
               
CURRENT LIABILITIES:              
  Bank revolving line of credit $ 979,688     $ 1,288,748  
  Current portion of notes payable   90,449       74,380  
  Accounts payable   1,078,527       1,259,865  
  Accounts payable – related parties   52,887       27,064  
  Accrued expenses   904,166       871,098  
  Deferred revenue         21,692  
               
  Total Current Liabilities   3,105,717       3,542,847  
               
LONG-TERM LIABILITIES:              
  Notes payable, net of current portion   266,110       312,139  
               
  Total Long-Term Liabilities   266,110       312,139  
               
  Total Liabilities   3,371,827       3,854,986  
               
Commitments and Contingencies              
               
STOCKHOLDERS’ DEFICIT:              
  Preferred stock, $0.0001 par value, 20,000,000 shares authorized; no shares issued and outstanding          
  Class A common stock: $0.0001 par value, 7,200,000 shares authorized; 1,367,431 and 1,336,759 issued and outstanding at December 31, 2016 and 2015, respectively   136       134  
  Class B common stock: $0.0001 par value, 2,500,000 shares authorized; 1,402,104 and 1,395,678 issued and outstanding at December 31, 2016 and 2015, respectively   140       139  
  Class Z common stock: $0.0001 par value, 300,000 shares authorized; 262,631 shares issued and outstanding at December 31, 2016 and 2015   26       26  
  Additional paid-in capital   5,321,769       5,071,532  
  Accumulated deficit   (5,900,167 )     (5,344,166 )
               
Total Stockholders’ Deficit   (578,096 )     (272,335 )
               
Total Liabilities and Stockholders’ Deficit $ 2,793,731     $ 3,582,651  
               
               
               
PEN INC. AND SUBSIDIARIES  
CONSOLIDATED STATEMENTS OF OPERATIONS  
                       
  For the Three Months Ended     For the Years Ended  
  December 31,     December 31,  
  2016     2015     2016     2015  
  (Unaudited)     (Unaudited)              
REVENUES:                              
  Products $ 1,720,642     $ 1,946,459     $ 7,111,947     $ 7,920,148  
  Contract services   199,188       346,731       1,003,710       1,764,924  
                               
  Total Revenues   1,919,830       2,293,190       8,115,657       9,685,072  
                               
COST OF REVENUES:                              
  Products   1,036,450       1,066,584       4,212,079       4,561,506  
  Research and development services   232,986       333,837       1,097,891       1,782,627  
                               
  Total Cost of Revenues   1,269,436       1,400,421       5,309,970       6,344,133  
                               
GROSS PROFIT   650,394       892,769       2,805,687       3,340,939  
                               
OPERATING EXPENSES:                              
  Selling and marketing expenses   42,755       65,574       220,029       280,173  
  Salaries, wages and related benefits   272,503       472,708       1,513,536       2,214,956  
  Research and development   53,868       124,055       290,402       744,346  
  Professional fees   148,787       113,962       513,237       660,584  
  General and administrative expenses   276,594       248,116       1,015,503       1,016,752  
  Impairment loss         188,051             188,051  
                               
  Total Operating Expenses   794,507       1,212,466       3,552,707       5,104,862  
                               
LOSS FROM OPERATIONS   (144,113 )     (319,697 )     (747,020 )     (1,763,923 )
                               
OTHER INCOME (EXPENSES):                              
  Interest expenses   (22,820 )     (26,848 )     (105,090 )     (117,879 )
  Other income, net   67,460       2,378       296,109       12,255  
                               
  Total Other Income/(Expense)   44,640       (24,470 )     191,019       (105,324 )
                               
NET LOSS $ (99,473 )   $ (344,167 )   $ (556,001 )   $ (1,869,247 )
                               
NET LOSS PER COMMON SHARE:                              
  Basic $ (0.03 )   $ (0.12 )   $ (0.18 )   $ (0.63 )
  Diluted $ (0.03 )   $ (0.12 )   $ (0.18 )   $ (0.63 )
                               
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:                              
  Basic   3,029,202       2,980,868       3,012,460       2,974,847  
  Diluted   3,029,202       2,980,868       3,012,460       2,974,847  
                                 
                                 
                                 
PEN INC. AND SUBSIDIARIES  
CONSOLIDATED STATEMENTS OF CASH FLOWS  
           
  For Years Ended  
  December 31,  
  2016     2015  
               
CASH FLOWS FROM OPERATING ACTIVITIES              
  Net loss $ (556,001 )   $ (1,869,247 )
  Adjustments to reconcile net loss to net cash provided by (used in) operating activities:              
    Change in inventory obsolescence reserve   56,861       (35,652 )
    Bad debt expense   12,021       641  
    Impairment loss         188,051  
    Depreciation and amortization expense   182,986       252,899  
    Amortization of deferred lease incentives   12,830       (12,830 )
    Change in value of stock appreciation rights         6,962  
    Change in value of equity credits         (11,024 )
    Gain on sale of property and equipment   (23,586 )      
    Loss on disposal of property and equipment   8,745        
    Gain on settlement of accounts payable   (50,879 )      
    Gain on settlement of accrued salary   (36,973 )      
    Stock-based compensation   202,240       241,240  
    Change in operating assets and liabilities:              
      Accounts receivable   365,486       (67,998 )
      Accounts receivable – related party   1,510       26,262  
      Inventory   (8,975 )     509,367  
      Prepaid expenses and other assets   100,895       14,867  
      Accounts payable   (130,459 )     (166,600 )
      Accounts payable – related parties   25,823       27,064  
      Accrued expenses   303,621       98,888  
      Deferred revenue   (21,692 )     (7,098 )
               
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES   444,453       (804,208 )
               
CASH FLOWS FROM INVESTING ACTIVITIES              
  Proceeds from sales of property and equipment   23,586        
  Purchases of property and equipment   (4,000 )     (248,123 )
               
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES   19,586       (248,123 )
               
CASH FLOWS FROM FINANCING ACTIVITIES              
  Proceeds from sale of common stock   50,000        
  Payment of issuance costs related to sale of common stock   (2,000 )      
  Proceeds from bank line of credit   6,815,000       8,156,000  
  Repayment of bank lines of credit   (7,319,231 )     (7,640,596 )
  Proceeds from bank loan         371,901  
  Repayment of bank loans   (74,380 )     (37,190 )
  Repayment of loan to third party   (6,819 )      
               
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES   (537,430 )     850,115  
               
NET DECREASE IN CASH   (73,391 )     (202,216 )
               
CASH, beginning of period   262,519       464,735  
               
CASH, end of period $ 189,128     $ 262,519  
               
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION              
Cash paid during the period for interest              
  Interest $ 105,090     $ 117,879  
  Income taxes $     $  
               
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:              
  Common stock issued for convertible notes and accrued interest $     $ 13,725  
  Common stock issued for accrued expenses $     $ 123,285  
  Reclassification of accrued salary to notes payable – long-term $ 51,239     $ 51,808  
                 

Kvaser Presents the Ethercan Light HS: The Simplest CAN-to-Ethernet Gateway Solution

CAN-to-Ethernet Gateway

Ethercan Light HS

Our aim is for our hardware to bring users greater access to all of CAN’s varied possibilities.

March 30, 2017: Meet the Ethercan Light HS, Kvaser’s answer to CAN-to-Ethernet connectivity. This compact, lightweight device fosters “Internet of Things”-type communication between other CAN hardware. More importantly, it allows users to access real-time CAN data remotely—something impossible with traditional USB connectivity. While primarily used in industrial automation and, more recently, the auto industry, the Ethercan Light HS has big implications for a wide array of sectors, including aerospace, defense, medical devices and innovative design, like robotics and large-scale solar equipment.

President Lars-Berno Fredriksson said of the innovative device, “Kvaser is proud to bring simple, well-designed CAN bus products, like the Ethercan, to the market. Our aim is for our hardware to bring users greater access to all of CAN’s varied possibilities.”

While CAN-to-Ethernet connectivity isn’t a new concept, it is one plagued by complex and cumbersome hardware. The Ethercan Light HS can detect and adjust for changing Ethernet cable connections (be it straight-through or crossover), and the gateway device ensures the smooth collection and transmission of real-time data, despite small internet disruptions. Additionally, the Ethercan features:

High-speed CAN connection, up to 1 Mb/s

PoE or with CAN devices, like the T-Cannector v2

Factory reset button for returning to default setting IP address

Full compatibility with J1939, CANopen, NME 2000R and DeviceNet

Lightweight, compact, galvanically isolated shell

To learn more about the Kvaser Ethercan Light HS, including detailed product specifications, click here.

About Kvaser: Kvaser is a world leading CAN development company. We provide advanced CAN solutions to engineers designing and deploying systems in areas as wide ranging as transportation (including electric vehicles), industrial automation, avionics, construction equipment, building automation, domestic appliances, marine, medical, military, railway, telecoms, textiles and more. Through well-developed, reliable hardware and lightweight, durable casings, our products are created to simplify the lives of our engineer customers.

Share article on social media or email:

Horse Dog & Cat Lovers Outlet & Designer Clothing Hub Launches Fashion Trove

PDF  View as PDF  Print View   

Carmel-based MyFavoriteTreasures.Online, in an online store that caters to the unique interests and loves of shoppers. By offering gifts and products for horse, cat and dog lovers, this new hub is emotive and memorable.

My Favorite Treasures Online, a ladies and men’s fashion boutique that specializes in clothing, shoes and fashion accessories, has launched an online shopping hub that caters to specific loves in the lives of everyday people. So, lovers of gardening, horses, dogs and cats can find a gift that caters to their interest or the interest of someone they love. Plus, shoppers using this unique hub, powered by Shopify, can buy many quality pieces at affordable prices.

More information is available at https://myfavoritetreasures.online.

Based in Carmel, Indiana, My Favorite Treasures Online newly launched store aims to introduce shoppers to unique and beautifully designed products that cannot necessarily be found elsewhere for the same outstanding price. For instance, the Horse Lovers range listed on the new fashion hub include clear crystal horseshoe earrings, a heart horse pendant, bracelet and wristband. These products make ideal gifts for friends, family and even as a reward for those seeking to spoil themselves.

Also selling beautiful women’s clothing and accessories such as belts and shoes that complement outfits, My Favorite Treasures Online brings shoppers the latest in fashion. With great savings and discounts, the new online hub makes shopping budget friendly and gives shoppers a lot for their money.

My Favorite Treasures Online also includes Men’s wear, such as stylish shirts in an array of colors and styles. Some of the best sellers include the Army Military Tooling Shirt and the European Fashion Designer Square Collar Shirt.

Striving to deliver a stunning array of products suited to people from various walks-of-life who have specific loves, My Favorite Treasures Online adds new products to the site at regular intervals. Thus, shoppers can frequently return to find gifts that are memorable and endearing.

When asked why they started the new online store, a spokesperson for My Favorite Treasures Online said, „We wanted to create an affordable shopping outlet that was out of the ordinary. By listing collections based on people’s loves, we feel we are offering a real treasure trove of gifts, rather than just another online store.”

To find out more about My Favorite Treasures Online and their new store, visit https://myfavoritetreasures.online.

Contact Info:
Name: Lois Wyant
Email: info@mygoto-usa.com
Organization: MyFavoriteTreasures.Online
Address: 240 East Main Street, Carmel, IN 46032, United States
Phone: +1-317-931-9665

For more information, please visit https://www.myfavoritetreasures.online/

Source: PressCable

Release ID: 181634

Recent Press Releases By The Same User

Custom Gift 40th Birthday Video Slideshow Scavenger Hunt Services Launched (Thu 30th Mar 17)

Automatic Transmission Fluid (ATF) Market 2017 Global Analysis, Opportunities and Forecast To 2022 (Thu 30th Mar 17)

Automatic Dependent Surveillance-Broadcast (ADS-B) System Market 2017 Global Analysis, Opportunities and Forecast To 2022 (Thu 30th Mar 17)

Fort Collins Laser Hair Removal Treatment Clinic Services Launched (Thu 30th Mar 17)

Bio Wax Market by Manufacturers,Types,Regions and Applications Research Report Forecast to 2022 (Thu 30th Mar 17)